Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: A before-after study

BMC Public Health

Volumn 7, Issue , 2007, Pages

  Bo, Simona ^a   Valpreda, Susanna ^a   Scaglione, Luca ^a   Boscolo, Daniela ^a   Piobbici, Marina ^b   Bo, Mario ^a   Ciccone, Giovannino ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CARDIAC PATIENT; CONFIDENCE INTERVAL; DRUG USE; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; STROKE; TREATMENT CONTRAINDICATION; VALVULAR HEART DISEASE; CEREBROVASCULAR ACCIDENT; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CONTRAINDICATION; FIBRINOLYTIC THERAPY; GERIATRIC ASSESSMENT; ITALY; ORAL DRUG ADMINISTRATION; RISK FACTOR; STANDARD; STATISTICAL MODEL; TEACHING HOSPITAL; TREATMENT OUTCOME; UTILIZATION REVIEW;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CEREBROVASCULAR ACCIDENT; CHEMOPREVENTION; DRUG UTILIZATION REVIEW; FEMALE; GERIATRIC ASSESSMENT; HOSPITALS, TEACHING; HUMANS; ITALY; LOGISTIC MODELS; MALE; PATIENT DISCHARGE; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; WARFARIN;

EID: 34948887766     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-7-203     Document Type: Article

References (32)

1. Atrial fibrillation and thromboembolism: a decade of progress in stroke prevention. RG Hart JL Halperin, Ann Intern Med 1999 131 688 695 10577332
2. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. WA Wattigney GA Mensah JB Croft, Circulation 2003 108 711 716 10.1161/01.CIR. 0000083722.42033.0A 12885749
3. Antithrombotic therapy. Edinburgh. Scottish Intercollegiate Guidelines Network, SIGN 1999 publication number 36
4. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). G Palareti N Leali S Coccheri M Poggi C Manotti A D'Angelo V Pengo N Erba M Moia N Ciavarella G Devoto M Berrettini S Musolesi, Lancet 1996 348 423 428 10.1016/S0140-6736(96) 01109-9 8709780
5. Oral anticoagulation and hemorrhagic complications in an elderly population with atrial fibrillation. M Copland ID Walker RC Tait, Arch Intern Med 2001 161 2125 2128 10.1001/archinte.161.17.2125 11570942
6. st century? S Bo G Ciccone L Scaglione C Taliano M Piobbici F Merletti G Pagano, Heart 2003 89 553 554 12695466 10.1136/heart.89.5.553
7. Risk factors for stroke and thromboprophylaxis in atrial fibrillation: what happens in daily clinical practice? P Laguna A Martín C Del Arco P Gargantilla, Ann Emerg Med 2004 44 3 11 10.1016/j.annemergmed.2004.01.010 15226703
8. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. AL Waldo RC Becker VF Tapson KJ Colgan, J Am Coll Cardiol 2005 46 1729 1736 10.1016/j.jacc.2005.06.077 16256877
9. Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy. RG Hart LA Pearce RM Rothbart JH McAnulty RW Asinger J Halperin, J Am Coll Cardiol 2000 35 183 187 10.1016/S0735-1097(99)00489-1 10636278
10. La terapia antitrombotica nella fibrillazione atriale non valvolare. http://www.cpo.it/lineeguida/TerapiaAntitrombotica.pdf
11. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation. C Van Walraven RG Hart DE Singer A Laupacis S Connolly P Petersen PJ Koudstaal Y Chang B Hellemons, JAMA 2002 288 2441 2448 10.1001/jama.288.19.2441 12435257
12. Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation. LM Brass HM Krumholz JD Scinto D Mathur M Radford, Arch Intern Med 1998 158 2093 2100 10.1001/archinte.158.19.2093 9801175
13. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. M Sudlow R Thomson B Thwaites H Rodgers RA Kenny, Lancet 1998 352 1167 1171 10.1016/S0140-6736(98)01401-9 9777832
14. Trends in utilization of antithrombotic therapy in patients with atrial fibrillation before stroke onset in a community-based study, from 1985 through 1997. GV Osseby I Benatru D Sochurkova R Urbinelli SE Megherbi G Couvreur T Moreau J Wolf M Giroud, Prev Med 2004 38 121 128 10.1016/j.ypmed.2003.09.002 14715203
15. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. AS Go EM Hylek LH Borowsky KA Phillips JV Selby DE Singer, Ann Intern Med 1999 131 927 934 10610643
16. The underutilization of cardiac medications of proven benefit, 1990 to 2002. RS Stafford DC Radley, J Am Coll Cardiol 2003 41 69 72 10.1016/S0735-1097(02)02670-0 12570947
17. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study). L Friberg N Hammar M Ringh H Petterson M Rosenqvist, Eur Heart J 2006 27 1954 1964 10.1093/eurheartj/ehl146 16847008
18. Improving management of atrial fibrillation and anticoagulation in a community hospital. GL Gaughan C Dolan E Wilk-Rivard G Geary R Libbey MA Gilman H Lanata, Jt Comm J Qual Improv 2000 26 18 28 10677819
19. Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomised trial. FA McAlister M Man-Son-Hing SE Straus WA Ghali D Anderson SR Majumdar P Gibson JL Cox M Fradette, CMAJ 2005 173 496 501 16129870
20. Implementation of antithrombotic management in atrial fibrillation. SJ McNulty D Hutchinson KJ Hardy, Postgrad Med J 2000 76 783 786 10.1136/pmj.76.902.783 11085769
21. A community-based educational intervention to improve antithrombotic drug use in atrial fibrillation. SL Jackson GM Peterson JH Vial, Ann Pharmacother 2004 38 1794 1799 10.1345/aph.1E152 15454583
22. Antithrombotic prescribing in atrial fibrillation: application of a prescribing indicator and multidisciplinary feedback to improve prescribing. RA Elliott MC Woodward CA Oborne, Age Aging 2002 31 391 396 10.1093/ageing/31.5.391
23. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention. BV Bajorek I Krass SJ Ogle MJ Duguid GM Shenfield, J Am Geriatr Soc 2005 53 1912 1920 10.1111/j.1532-5415.2005.53564.x 16274372
24. Why do patients with atrial fibrillation not receive warfarin? TJ Bungard WA Ghali KK Teo FA McAlister RT Tsuyuki, Arch Intern Med 2000 160 41 46 10.1001/archinte.160.1.41 10632303
25. Perceived risk for developing stroke among older adults. TS Harwell LL Blades CS Oser DW Dietrich NJ Okon DV Rodriguez AM Burnett JA Russell MJ Allen CC Fogle SD Helgerson D Gohdes, Prev Med 2005 41 791 794 10.1016/j.ypmed.2005. 07.003 16102802
26. Warfarin in atrial fibrillation: underused in the elderly, often inappropriately used in the young. RG Hart, Heart 1999 82 539 540 10525502
27. Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. L Scaglione M Piobbici E Pagano L Ballini G Tamponi G Ciccone, Haematologica 2005 90 678 684 15921383
28. The need for intelligent efforts. L Baruch RA Phillips, Arch Intern Med 2005 165 1455 1456 10.1001/archinte.165.13.1455 16009859
29. Validation of clinical classification schemes for predicting stroke. BF Gage AD Waterman W Shannon M Boechler MW Rich MJ Radford, JAMA 2001 285 2864 2870 10.1001/jama.285.22.2864 11401607
30. 2 score. D Poli E Antonucci R Marcucci C Fatini B Alterini L Mannini M Falciani R Abbate GF Gensini D Prisco, Thromb Res 2007 doi: 10.1016 17597186
31. Antithrombotic therapy in atrial fibrillation. A Laupacis G Albers J Dalen MI Dunn AK Jacobson DE Singer, Chest 1998 114 579S 589S 9822064
32. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary. J Am Coll Cardiol 2006 48 854 906 10.1016/j.jacc.2006.07.009 16904574